Sirona Biochem Corp  

(Public, CVE:SBM)   Watch this stock  
Find more results for SBM
0.000 (0.00%)
Nov 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.13 - 0.14
52 week 0.12 - 0.19
Open 0.14
Vol / Avg. 10,600.00/102,193.00
Mkt cap 23.21M
P/E     -
Div/yield     -
EPS -0.02
Shares 165.80M
Beta 0.28
Inst. own     -

Key stats and ratios

Q3 (Jul '17) 2016
Net profit margin -27514.54% -825.18%
Operating margin -26480.62% -815.20%
EBITD margin - -772.65%
Return on average assets -91.47% -75.59%
Return on average equity -2337.47% -152.11%
CDP Score - -


889 Pender St W Suite 605
+1-604-6414466 (Phone)
+1-604-6083951 (Fax)

Website links


Sirona Biochem Corp. is a Canada-based development-stage cosmetic ingredient and drug discovery company with a technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. It is engaged in the development of cosmetic and pharmaceutical active ingredients, which are licensed to its partners. The Company has six product lines: SGLT2 Inhibitor, Skin Lightener I, GlycoProteMin-Anti aging, Anti-inflammatory, Anti-infective and Skin Lightener II. Its development is focused on three programs: therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; cosmeceuticals, which includes anti-aging and depigmenting agents (skin lighteners), and biological ingredients, which includes inducers and adjuvants for biological development and preservation. The Company, through TFChem S.A.R.L. (TFC), is engaged in using fluorine atom properties to develop glycomimetic compounds.

Officers and directors

Howard Verrico M.D. Chairman of the Board, Interim Chief Executive Officer, Founder, Secretary
Christopher D. Hopton Chief Financial Officer, Director
Geraldine Deliencourt-Godefroy Chief Scientific Officer, Director
Attila Hajdu Chief Business Development Officer
Casper K Bych Director
Age: 41
Alex Marazzi Independent Director